These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7566623)

  • 1. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients.
    Morales JM; Muñoz MA; Fernández Zataraín G; García Cantón C; García Rubiales MA; Andrés A; Aguado JM; Gonzalez Pinto I
    Nephrol Dial Transplant; 1995; 10(6):882-3. PubMed ID: 7566623
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure associated with foscarnet therapy.
    Navarro JF; Mora C; Gallego E; García J
    Nephrol Dial Transplant; 1996 Jan; 11(1):221. PubMed ID: 8649644
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
    Ehlert K; Groll AH; Kuehn J; Vormoor J
    Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure induced by foscarnet: 4 cases.
    Cacoub P; Deray G; Baumelou A; Le Hoang P; Rozenbaum W; Gentilini M; Soubrie C; Rousselie R; Jacobs C
    Clin Nephrol; 1988 Jun; 29(6):315-8. PubMed ID: 2840226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).
    Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint MT; Moro F; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont AM
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():110-4. PubMed ID: 8932810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
    Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine.
    Minetti EE; Minetti L
    J Nephrol; 2003; 16(3):421-5. PubMed ID: 12832745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.
    Moretti S; Zikos P; Van Lint MT; Tedone E; Occhini D; Gualandi F; Lamparelli T; Mordini N; Berisso G; Bregante S; Bruno B; Bacigalupo A
    Bone Marrow Transplant; 1998 Jul; 22(2):175-80. PubMed ID: 9707026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penile erosions associated with foscarnet therapy in a child.
    Hick RW; Prose N
    Pediatr Dermatol; 2010; 27(3):302-3. PubMed ID: 20609154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation.
    Wang H; Zhu L; Xue M; Liu J; Guo Z
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):519-20. PubMed ID: 19285642
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute pancreatitis, acute hepatitis and acute renal failure favourably resolved in two renal transplant recipients.
    Voiculescu M; Ionescu C; Ismail G; Mandache E; Hortopan M; Constantinescu I; Iliescu O
    Rom J Gastroenterol; 2003 Mar; 12(1):41-6. PubMed ID: 12673379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon.
    Halmos O; Inturri P; Galligioni A; Di Landro D; Rigotti P; Tedeschi U; Graziotto A; Burra P; Poletti A; Rossaro L
    Clin Transplant; 1996 Aug; 10(4):374-8. PubMed ID: 8884111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foscarnet-induced hypercalcaemia in AIDS.
    Gayet S; Ville E; Durand JM; Mars ME; Morange S; Kaplanski G; Gallais H; Soubeyrand J
    AIDS; 1997 Jul; 11(8):1068-70. PubMed ID: 9223751
    [No Abstract]   [Full Text] [Related]  

  • 15. Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
    Bregante S; Bertilson S; Tedone E; Van Lint MT; Trespi G; Mordini N; Berisso G; Gualandi F; Lamparelli T; Figari O; Benvenuto F; Raiola AM; Bacigalupo A
    Bone Marrow Transplant; 2000 Jul; 26(1):23-9. PubMed ID: 10918402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.
    Launay-Vacher V; Izzedine H; Deray G
    Int J Cardiol; 2005 May; 101(1):9-17. PubMed ID: 15860377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E; Kallas WM; Fishman JA
    Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.
    Openshaw H; Slatkin NE; Smith E
    Bone Marrow Transplant; 1997 Mar; 19(5):503-5. PubMed ID: 9052919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular foscarnet crystal precipitation causing multiorgan failure.
    Philipponnet C; Michel PA; Daudon M; Brocheriou I; Boffa JJ
    Am J Kidney Dis; 2015 Jan; 65(1):152-5. PubMed ID: 25301103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tolerance of combined treatment with foscarnet and indinavir.
    Guery B; Katlama C; Bochet M; Deray G
    Nephrol Dial Transplant; 1998 Mar; 13(3):815-6. PubMed ID: 9550685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.